XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Product Information [Line Items]          
Cash equivalents $ 0   $ 0   $ 0
Accounts receivable 49,644,417   49,644,417   32,639,242
Cash in excess of federally insured limits 923,023   $ 923,023   686,177
Estimated useful life     3 to 10 years    
Goodwill 4,487,637   $ 4,487,637   $ 0
Revenues 21,596,478 $ 15,256,431 59,272,980 $ 42,778,104  
Other Income [Member] | Breakage Revenue [Member]          
Product Information [Line Items]          
Revenues 254,543 19,331 410,667 106,117  
Other Income [Member] | Settlement Revenue [Member]          
Product Information [Line Items]          
Revenues 0 $ 0 $ 0 $ 0  
Intangible Assets [Member]          
Product Information [Line Items]          
Estimated useful life     3 to 15 years    
Contract Assets [Member]          
Product Information [Line Items]          
Estimated useful life     three to five years    
Hosting Implementation [Member]          
Product Information [Line Items]          
Estimated useful life     three year    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Pharma Program Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage     14.00%   17.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Second Pharma Program Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage         15.00%
Reimbursement Receivables [Member]          
Product Information [Line Items]          
Accounts receivable $ 41,439,319   $ 41,439,319   $ 27,566,694